Polylactic acid(PLA)bioplastic is a common material used in Fused Deposition Modeling(FDM)3D printing.It is biodegradable and environmentally friendly biopolymer which made out of corn.However,it exhibits weak mechan...Polylactic acid(PLA)bioplastic is a common material used in Fused Deposition Modeling(FDM)3D printing.It is biodegradable and environmentally friendly biopolymer which made out of corn.However,it exhibits weak mechanical properties which reduced its usability as a functional prototype in a real-world application.In the present study,two PLA composites are created through coextruded with 3K carbon fibres and twisted Kevlar string(as core fibre)to form a fibre reinforced parts(FRP).The mechanical strength of printed parts was examined using ASTM D638 standard with a strain rate of 1 mm/min.It has been demonstrated that the FRPs coextruded with 3K carbon fibres had achieved significant improvement in Young’s modulus(+180.6%,9.205 GPa),ultimate tensile strength(+175.3%,103 MPa)and maximum tensile strain(+21.6%,1.833%).Although the Young’s modulus of Kevlar FRP was found to be similar to as compared to unreinforced PLA(~3.29 GPa),it has gained significant increment in terms of maximum tensile strain(+179.7%,104.64 MPa),and maximum tensile strain(+257%,5.384%).Thus,this study revealed two unique composite materials,in which the 3K carbon FRP can offer stiff and high strength structure while Kevlar FRP offers similar strength but at a higher elasticity.展开更多
磷脂酰肌醇3-激酶(PI3Ks)作为酪氨酸激酶和G蛋白偶联受体的主要下游分子,通过催化产生第二信使3,4,5-三磷酸磷脂酰肌醇(PIP3)并激活Akt、糖原合酶激酶-3(GSK-3)、Forkhead转录因子FoxO1、mTOR(mammalian target of rapamycin)等下游分子...磷脂酰肌醇3-激酶(PI3Ks)作为酪氨酸激酶和G蛋白偶联受体的主要下游分子,通过催化产生第二信使3,4,5-三磷酸磷脂酰肌醇(PIP3)并激活Akt、糖原合酶激酶-3(GSK-3)、Forkhead转录因子FoxO1、mTOR(mammalian target of rapamycin)等下游分子,将多种生长因子及细胞因子的信号传递到细胞内,从而对细胞增殖、分化、凋亡和葡萄糖转运等多种生物过程起重要的调节作用.PTEN(phosphatase and tensin homologue)是PI3K信号通路的重要负调节因子.本文将对PI3K-Akt信号通路在糖代谢中的作用予以简要综述.展开更多
Idiopathic pulmonary fibrosis(IPF) is a chronic progressive fibrotic interstitial pneumonia with unknown causes. The incidence rate increases year by year and the prognosis is poor without cure.Recently, phosphatidyli...Idiopathic pulmonary fibrosis(IPF) is a chronic progressive fibrotic interstitial pneumonia with unknown causes. The incidence rate increases year by year and the prognosis is poor without cure.Recently, phosphatidylinositol 3-kinase(PI3 K)/protein kinase B(PKB/AKT) signaling pathway can be considered as a master regulator for IPF. The contribution of the PI3 K/AKT in fibrotic processes is increasingly prominent, with PI3 K/AKT inhibitors currently under clinical evaluation in IPF. Therefore,PI3 K/AKT represents a critical signaling node during fibrogenesis with potential implications for the development of novel anti-fibrotic strategies. This review epitomizes the progress that is being made in understanding the complex interpretation of the cause of IPF, and demonstrates that PI3 K/AKT can directly participate to the greatest extent in the formation of IPF or cooperate with other pathways to promote the development of fibrosis. We further summarize promising PI3 K/AKT inhibitors with IPF treatment benefits, including inhibitors in clinical trials and pre-clinical studies and natural products, and discuss how these inhibitors mitigate fibrotic progression to explore possible potential agents, which will help to develop effective treatment strategies for IPF in the near future.展开更多
基金This project is funded by Universiti Tunku Abdul Rahman through the grant number IPSR/RMC/UTARRF/2018-C2/T02.
文摘Polylactic acid(PLA)bioplastic is a common material used in Fused Deposition Modeling(FDM)3D printing.It is biodegradable and environmentally friendly biopolymer which made out of corn.However,it exhibits weak mechanical properties which reduced its usability as a functional prototype in a real-world application.In the present study,two PLA composites are created through coextruded with 3K carbon fibres and twisted Kevlar string(as core fibre)to form a fibre reinforced parts(FRP).The mechanical strength of printed parts was examined using ASTM D638 standard with a strain rate of 1 mm/min.It has been demonstrated that the FRPs coextruded with 3K carbon fibres had achieved significant improvement in Young’s modulus(+180.6%,9.205 GPa),ultimate tensile strength(+175.3%,103 MPa)and maximum tensile strain(+21.6%,1.833%).Although the Young’s modulus of Kevlar FRP was found to be similar to as compared to unreinforced PLA(~3.29 GPa),it has gained significant increment in terms of maximum tensile strain(+179.7%,104.64 MPa),and maximum tensile strain(+257%,5.384%).Thus,this study revealed two unique composite materials,in which the 3K carbon FRP can offer stiff and high strength structure while Kevlar FRP offers similar strength but at a higher elasticity.
文摘磷脂酰肌醇3-激酶(PI3Ks)作为酪氨酸激酶和G蛋白偶联受体的主要下游分子,通过催化产生第二信使3,4,5-三磷酸磷脂酰肌醇(PIP3)并激活Akt、糖原合酶激酶-3(GSK-3)、Forkhead转录因子FoxO1、mTOR(mammalian target of rapamycin)等下游分子,将多种生长因子及细胞因子的信号传递到细胞内,从而对细胞增殖、分化、凋亡和葡萄糖转运等多种生物过程起重要的调节作用.PTEN(phosphatase and tensin homologue)是PI3K信号通路的重要负调节因子.本文将对PI3K-Akt信号通路在糖代谢中的作用予以简要综述.
基金supported by the National Natural Science Foundation of China(No.82003873)the Postdoctoral Science Foundation of China(No.2020M681899)the Zhejiang Provincial Natural Science Foundation of China(No.LR21H310001)。
文摘Idiopathic pulmonary fibrosis(IPF) is a chronic progressive fibrotic interstitial pneumonia with unknown causes. The incidence rate increases year by year and the prognosis is poor without cure.Recently, phosphatidylinositol 3-kinase(PI3 K)/protein kinase B(PKB/AKT) signaling pathway can be considered as a master regulator for IPF. The contribution of the PI3 K/AKT in fibrotic processes is increasingly prominent, with PI3 K/AKT inhibitors currently under clinical evaluation in IPF. Therefore,PI3 K/AKT represents a critical signaling node during fibrogenesis with potential implications for the development of novel anti-fibrotic strategies. This review epitomizes the progress that is being made in understanding the complex interpretation of the cause of IPF, and demonstrates that PI3 K/AKT can directly participate to the greatest extent in the formation of IPF or cooperate with other pathways to promote the development of fibrosis. We further summarize promising PI3 K/AKT inhibitors with IPF treatment benefits, including inhibitors in clinical trials and pre-clinical studies and natural products, and discuss how these inhibitors mitigate fibrotic progression to explore possible potential agents, which will help to develop effective treatment strategies for IPF in the near future.
